Non-alcoholic fatty liver disease (NAFLD) and Health-related quality of life (HR-QoL): Findings from the Horizon 2020 'FOIE GRAS' project

被引：0
|
作者：
Shanmugam, H. [1 ,2 ]
Di Ciaula, A. [1 ]
Krawczyk, M. [3 ,4 ]
Molina, E. Molina [1 ]
Serale, N. [1 ,2 ]
Khalil, M. [1 ,2 ]
Milkiewicz, P. [5 ]
Portincasa, P. [1 ]
机构：
[1] Univ Bari, Med Sch, Clin Med A Murri, Dept Biomed Sci & Human Oncol, Bari, Italy
[2] Univ Bari Aldo Moro, Dept Soil & Food Sci, Bari, Italy
[3] Saarland Univ, Saarland Univ Homburg Germany, Med Ctr, Dept Med 2, Homburg, Germany
[4] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Ctr Preclin Res, Lab Metab Liver Dis, Warsaw, Poland
[5] Med Univ Warsaw Hosp, European Reference Network ERN, Warsaw, Poland
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2021年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
55ASM-0197
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [21] The heart of FOIE GRAS and mtFOIE GRAS: fundamental and clinical investigation for training and innovation in non-alcoholic fatty liver disease
    Oliveira, Paulo J.
    EUROPEAN HEART JOURNAL, 2022, 43 (05) : 357 - 359
  • [22] BMI and health-related quality of life (HR-QoL) in patients with metastatic colorectal cancer (mCRC).
    Formica, Vincenzo
    Nardecchia, Antonella
    Pellegrino, Rachela
    Massimiliani, Valentina
    Donnarumma, Luisa
    Giuliano, Greta
    Renzi, Nicola
    Mariotti, Sabrina
    Portarena, Ilaria
    Laudisi, Anastasia
    Morelli, Cristina
    Lucchetti, Jessica
    Perrone, Lorena
    Riondino, Silvia
    Roselli, Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31)
  • [23] A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD
    Younossi, Zobair M.
    Stepanova, Maria
    Henry, Linda
    Racila, Andrei
    Lam, Brian
    Pham, Huong T.
    Hunt, Sharon
    LIVER INTERNATIONAL, 2017, 37 (08) : 1209 - 1218
  • [24] A national cross-sectional survey of health-related quality of life in Chinese patients with non-alcoholic fatty liver disease
    Huang, Rui
    Fan, Jiangao
    Shi, Junping
    Mao, Yimin
    Wang, Bingyuan
    Zhao, Jingmin
    Lu, Lungen
    Zhong, Bihui
    Zou, Zhengsheng
    Xu, Youqing
    Ye, Yinong
    Liu, Longgen
    Lin, Lianjie
    Li, Jianping
    Wei, Lai
    Rao, Huiying
    JOURNAL OF HEPATOLOGY, 2020, 73 : S167 - S168
  • [25] Association between Non-Alcoholic Fatty Liver Disease and Dietary Habits, Stress, and Health-Related Quality of Life in Korean Adults
    Han, A. Lum
    NUTRIENTS, 2020, 12 (06)
  • [26] The Polistena project on non-alcoholic fatty liver disease (NAFLD): A study of risk factors
    Lonardo, A
    Loria, P
    Leonardi, F
    Neri, P
    Pulvirenti, M
    Borsatti, A
    Verrone, AM
    Bortolotti, M
    De Micheli, EA
    Carulli, N
    GASTROENTEROLOGY, 2001, 120 (05) : A117 - A117
  • [27] Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
    Tacke, Frank
    Weiskirchen, Ralf
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [28] No association of cART and HIV-related parameters with health-related quality of life (HR-QoL) of PLWH: insights from a multidimensional screening
    Capodieci, Stella
    Zaccarelli, Mauro
    Latini, Alessandra
    Stingone, Christof
    Gianserra, Laura
    Dona, Maria Gabriella
    Giuliani, Eugenia
    Cafaro, Valentina
    Giuliani, Massimo
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 289 - 290
  • [29] Health-related quality of life (HR-QOL) and regulatory issues - An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approval
    Apolone, G
    De Carli, G
    Brunetti, M
    Garattini, S
    PHARMACOECONOMICS, 2001, 19 (02) : 187 - 195
  • [30] Health-Related Quality of Life (HR-QOL) and Regulatory IssuesAn Assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) Recommendations on the Use of HR-QOL Measures in Drug Approval
    Giovanni Apolone
    Gianfranco De Carli
    Massimo Brunetti
    Silvio Garattini
    PharmacoEconomics, 2001, 19 : 187 - 195
12345